SCHEMBL931735

SCHEMBL931735

CCC(=O)N1CCN(C(C)C(N)=O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.41
POLB P06746 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 3/20 0.36
EPHX2 P34913 2/20 0.36
CHRNB2 P17787 2/20 0.35
CHRNA3 P32297 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNB3 Q05901 1/20 0.35
CHRNA6 Q15825 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
CHRNB4 P30926 1/20 0.34
CHRNA7 P36544 1/20 0.34
GNAI3 P08754 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763417 0.84 ALDH1A1 (0.35) POLBNPSR1L3MBTL1KDM4EMEN1
SCHEMBL16026595 0.82 MEN1 (0.37) KDM4EMEN1KMT2AALDH1A1CHRNB2
SCHEMBL10154480 0.80 HRH3 (0.46) BLMPOLBNPSR1L3MBTL1KDM4E
SCHEMBL13472662 0.79 ALDH1A1 (0.46) BLMPOLBNPSR1L3MBTL1MEN1
SCHEMBL4682780 0.79 BLM (0.44) BLMPOLBNPSR1L3MBTL1KDM4E
SCHEMBL4723629 0.79 PIK3CD (0.47) KDM4EKMT2AALDH1A1EPHX2
SCHEMBL4682783 0.79 BLM (0.44) BLMPOLBNPSR1L3MBTL1KDM4E
SCHEMBL4724913 0.79 PIK3CD (0.47) KDM4EKMT2AALDH1A1EPHX2
SCHEMBL946054 0.77 KDM4E (0.38) BLMKDM4EALDH1A1TP53
SCHEMBL20621109 0.77 KDM4E (0.56) BLMPOLBNPSR1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO claimed